Italia markets open in 1 hour 25 minutes

China Resources Beer (Holdings) Company Limited (0291.HK)

HKSE - HKSE Prezzo differito. Valuta in HKD.
Aggiungi a watchlist
54,300+0,450 (+0,84%)
Al 01:20PM HKT. Mercato aperto.
Schermo intero
Chiusura precedente53,850
Aperto53,250
Denaro54,000 x 0
Lettera54,300 x 0
Min-Max giorno52,500 - 54,300
Intervallo di 52 settimane38,400 - 70,650
Volume7.555.353
Media Volume10.796.104
Capitalizzazione176,149B
Beta (5 anni mensile)0,74
Rapporto PE (ttm)32,91
EPS (ttm)1,650
Prossima data utili15 ago 2022 - 19 ago 2022
Rendimento e dividendo (forward)0,67 (1,20%)
Data ex dividendo23 giu 2022
Stima target 1A64,80
  • GlobeNewswire

    Zealand Pharma Completes Enrollment in Phase 3 Trial of Dasiglucagon in Children with Congenital Hyperinsulinism (CHI)

    Company announcement – No. 4 / 2022 Zealand Pharma Completes Enrollment in Phase 3 Trial of Dasiglucagon in Children with Congenital Hyperinsulinism (CHI) Top-line results expected in the second quarter of 2022Pending positive results, Zealand intends to file for marketing approval with the US Food and Drug Administration Copenhagen, DK and Boston, MA, U.S. February 15, 2022 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery, development and

  • GlobeNewswire

    Zealand Pharma increases its share capital as a consequence of exercise of employee warrants

    Company announcement – No. 74 / 2021 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, DK and Boston, MA, U.S. December 10, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, has increased its share capital by a nominal amount of DKK 5,400 divided into 5,400 new shares with a nominal value of DKK 1 each. The in

  • GlobeNewswire

    Zealand Pharma major shareholder announcement: The Capital Group Companies, 2021

    Company announcement – No. 73 / 2021 Zealand Pharma major shareholder announcement: The Capital Group Companies, 2021 Copenhagen, DK and Boston, MA, November 30, 2021 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announces the receipt of notification pursuant to Section 38 of the Danish Capital Markets Act from the following major shareholders: T